Encapsulation of doxorubicin in neutral liposomes by passive methods: evidence of drug-lipid interaction at neutral pH

References

• Burke T.G., Tritton T.R. Location and dynamics of anthracyclines bound to unilamellar phosphatidylcholine vesicles. Biochemistry 1985; 24: 5972–5980
   PubMed Web of Science ®Google Scholar
• Constantinides P.P., Tritton T.R., Sartorelli A.C. Interaction of adriamycin with single and multibilayer dipalmitoylphosphatidylcholine vesicles: spinlabeling and calorimetric study. Journal of Liposome Research 1989a; 1: 135–62
   Google Scholar
• Constantinides P.P., Inouchi N., Sartorelli A.C., Sturtevant J.M. Interaction of adriamycin and N-trifluoroacetyladriamycin-14-valerate with cardiolipin-containing lipid bilayers. Journal of Liposome Research 1989b; 1(2)245–260
   Google Scholar
• Creaven P.J., Cowens J.W., Ginsberg R., Ostro M., Brownan G. Clinical studies with liposomal doxorubicin. Journal of Liposome Research 1980; 4: 481–490
   Google Scholar
• Crommelin D.J.A., Slaats N., Van Bloois L. Preparation and characterization of doxorubicin-containing liposomes. I. Influence of liposome charge and pH of hydration medium on loading capacity and particle size. International Journal of Pharmaceutics 1983a; 16: 79–92
   Web of Science ®Google Scholar
• Crommelin D.J.A., Van Bloois L. Preparation and characterization of doxorubicin containing liposomes. II. Loading capacity, long-term stability and doxorubicin-bilayer interaction mechanism. International Journal of Pharmaceutics 1983b; 17: 135–144
   Web of Science ®Google Scholar
• Crossey R.J. Personal communication at ‘Liposomes in drug delivery: 21 years on’ Conference, London, December, 12–151990
   Google Scholar
• Dupou-Cézanne L., Satereau A.M., Tocanne J.F. Localization of adriamycin in model and natural membranes. Influence of lipid molecular packing. European Journal of Biochemistry, 181: 695–702
   PubMedGoogle Scholar
• Gabizon A., Dagan A., Goren D., Barenholz Y., Fuks Z. Liposomes as in vivo carriers of adriamycin: reduced cardiac uptake and preserved antitumor activity in mice. Cancer Research 1982; 42: 4734–4739
   PubMed Web of Science ®Google Scholar
• Gabizon A., Amselem S., Goren D., Cohen R., Druckmann S., Fromer I., Chisin R., Peretz T., Sulkkes A., Barenholz Y. Preclinical and clinical experiences with a doxorubicin liposome preparation. Journal of Liposome Research 1990; 4: 491–502
   Google Scholar
• Giuliani A.M., Boicelli C.A., De Angelis L., Giomini M., Giustini M., Trotta E. Doxorubicin interactions with neutral phospholipids: and infrared and thermal analysis study. Studia Biophysica 1988; 123: 45–52
   Google Scholar
• Goormaghtigh E., Chatelain P., Caspers J., Ruysschaert J.M. Evidence of a specific complex between adriamycin and negatively-charged phospholipids. Biochimica et Biophysica Acta 1980; 597: 1–14
   PubMed Web of Science ®Google Scholar
• Goormaghtigh E., Ruysschaert J.M. Anthracycline glycoside-membrane interactions. Biochimica et Biophysica Acta 1984; 779: 271–288
   PubMed Web of Science ®Google Scholar
• Hernández J., Estelrich J., Pouplana R. Determination of encapsulation efficiency in liposomes obtained by the ‘extruder method’. Journal of Microencapsulation 1987; 4: 315–320
   PubMed Web of Science ®Google Scholar
• Hernandez J., Montero T., Estelrich J., Valls O. The action of indomethacin on neutral and positively charged monolayers. Colloid Polymer Science 1989; 267: 622–626
   Web of Science ®Google Scholar
• Hernandez J., Aliño S., Valls O. Caracteristicas de los liposomas formados con lípìdos ligados a medicamentos. Anales de Quimica 1990; 16
   Google Scholar
• Henry-Toulme N., Stefanska B., Borowski E., Bolard J. Structural basis for the binding of antitumor anthracycline antibiotics to model membranes: circular dichroism studies. Molecular Pharmacology 1988; 33: 574–579
   PubMed Web of Science ®Google Scholar
• Janssen M.J.H., Crommelin D.J.A., Hulshoff A. Doxorubicin decomposition on storage. Effect of pH, type of buffer and liposome encapsulation. International Journal of Pharmaceutics 1985; 23: 1–11
   Web of Science ®Google Scholar
• Karczmar G.S., Tritton T.R. The interaction of adriamycin with unilamellar vesicles liposomes. A fluorescence study. Biochimica et Biophysica Acta 1979; 557: 306–319
   PubMed Web of Science ®Google Scholar
• Koppel D.E. Analysis of macromolecular polydispersity in intensity correlation spectroscopy: the method of cumulants. Journal of Chemistry and Physics 1972; 67: 4814–4820
   Google Scholar
• Lasic D.D. The mechanism of vesicle formation. Biochemistry Journal 1988; 256: 1–11
   PubMed Web of Science ®Google Scholar
• Mayer L.D., Bally M.B., Cullis P.R. Uptake of adriamycin into large unilamellar vesicles in response to a pH gradient. Biochimica et Biophysica Acta 1986a; 857: 123–126
   PubMed Web of Science ®Google Scholar
• Mayer L.D., Hope M.J., Cullis P.R. Vesicles of variable sizes produced by a rapid extrusion procedure. Biochimica et Biophysica Acta 1986b; 858: 161–168
   PubMed Web of Science ®Google Scholar
• Mayer L.D., Tai L.C.L., Ko D.S.C., Masin D., Ginsberg R.S., Cullis P.R., Bally M.B. Influence of vesicle size, lipid composition, and drug-to-lipid ratio on the biological activity of liposomal doxorubicin in mice. Cancer Research 1989; 49: 5922–5930
   PubMed Web of Science ®Google Scholar
• Mayer L.D., Bally M.B., Cullis P.R. Strategies for optimizing liposomal doxorubicin. Journal of Liposome Research 1980; 4: 463–480
   Google Scholar
• Mayhew E., Rustun Y., Vail W.J. Inhibition of liver metastases of M5076 tumor by liposome-entrapped adriamycin. Cancer Drug Delivery 1983; 1: 43–58
   PubMedGoogle Scholar
• Murphree S.A., Murphy D., Sartorelli A.C., Tritton T.R. Adriamycin-liposome interactions. A magnetic resonance study of the differential effects of cardiolipin on drug-induced fusion and permeability. Biochimica et Biophysics Acta 1982; 691: 97–105
   PubMed Web of Science ®Google Scholar
• Noé Ch., Hernandez-Borrell J., Kinsky S.C., Matsuura E., Leserman L. Inhibition of cell proliferation with antibody-targeted liposomes containing methotrexate-γ-dimiristoylphosphatidyl-ethanolamine. Biochimica et Biophysica Acta 1988; 946: 253–260
   PubMed Web of Science ®Google Scholar
• Perez-Soler R. Liposomes as carriers of antitumor agents: toward a clinical reality. Cancer Treatment Reviews 1989; 16: 67–82
   PubMed Web of Science ®Google Scholar
• Rand R.P., Parsegian V.A. Physical force considerations in model and biological membranes. Canadian Journal of Biochemistry and Cell Biology 1984; 62: 752–759
   PubMedGoogle Scholar
• Stewart Ch.J.M. Colorimetric determination of phospholipids with ammonium ferrothyocyanate. Analytical Biochemistry 1980; 104: 10–14
   PubMed Web of Science ®Google Scholar
• Van Bommel E.M.G., Crommelin D.J.A. Stability of doxorubicin-liposomes on storage: as an aqueous dispersion, frozen or freeze-dried. International Journal of Pharmaceutics 1984; 22: 299–310
   Web of Science ®Google Scholar
• Van Hoesel Q. G. C.M., Steerenberg P.A., Hillen F. Reduced cardiotoxicity and nephrotoxicity with preservation of antitumor activity of doxorubicin entrapped in stable liposomes in the Lou/M Wsl rat. Cancer Research 1984; 44: 3698–3705
   PubMed Web of Science ®Google Scholar